The Royal Hospital for Women is a specialist hospital for women and babies located in the suburb of Randwick in Sydney, New South Wales, Australia.

During the past decade, Royal Hospital for Women conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Hospital for Women" #1 sponsor was "Murdoch Childrens Research Institute" with 3 trials, followed by "University of Sydney" with 3 trials sponsored, "Ausio Pharmaceuticals, LLC" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Hologic, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Hospital for Women" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Royal Children's Hospital" with 2 trials as a collaborator, "Royal Hospital For Women" with 2 trials as a collaborator, "Sydney Children's Hospitals Network" with 2 trials as a collaborator and "Australian Government Department of Health and Ageing" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Royal Hospital for Women" are "Bacteremia" (2 trials), "Infection" (2 trials), "Sepsis" (2 trials), "Autosomal Recessive Disorder" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Royal Hospital for Women" in a lesser frequency.

Most popular intervention types in "Royal Hospital for Women" are "Drug" (7 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Adiana Transcervical Sterilization System" (1 trials), "Continuous Positive Airway Pressure Ventilation (CPAP)" (1 trials), "Continuous infusion of vancomycin" (1 trials) and "Deferred cord clamping" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Hospital for Women" are 7 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Royal Hospital for Women". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Royal Hospital for Women, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Hospital for Women, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".